Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project.
Adamo M, Provini M, Fiorina C, Giannini C, Angelillis M, Testa L, Barbanti M, Merlanti B, Poli A, Ferrara E, Latib A, Reimers B, Maffeo D, Bruschi G, Montorfano M, Petronio AS, Bedogni F, Tamburino C, Metra M, Curello S. Adamo M, et al. Among authors: angelillis m. Catheter Cardiovasc Interv. 2020 Dec;96(7):1500-1508. doi: 10.1002/ccd.28927. Epub 2020 Jul 9. Catheter Cardiovasc Interv. 2020. PMID: 32644300
Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
Montone RA, Testa L, Fraccaro C, Montorfano M, Castriota F, Nerla R, Angelillis M, Tusa M, Giannini F, Garatti A, Tarantini G, Petronio AS, Brambilla N, Bedogni F. Montone RA, et al. Among authors: angelillis m. Catheter Cardiovasc Interv. 2017 Dec 1;90(7):1206-1211. doi: 10.1002/ccd.26914. Epub 2017 Feb 1. Catheter Cardiovasc Interv. 2017. PMID: 28145039
Prognostic Significance of Change in the Left Ventricular Ejection Fraction After Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis and Left Ventricular Dysfunction.
Angelillis M, Giannini C, De Carlo M, Adamo M, Nardi M, Colombo A, Chieffo A, Bedogni F, Brambilla N, Tamburino C, Barbanti M, Bruschi G, Colombo P, Poli A, Martina P, Violini R, Presbitero P, Petronio AS. Angelillis M, et al. Am J Cardiol. 2017 Nov 1;120(9):1639-1647. doi: 10.1016/j.amjcard.2017.07.064. Epub 2017 Aug 1. Am J Cardiol. 2017. PMID: 28844511
MicroRNAs distribution in different phenotypes of Aortic Stenosis.
Fabiani I, Pugliese NR, Calogero E, Conte L, Mazzanti MC, Scatena C, Scopelliti C, Tantillo E, Passiatore M, Angelillis M, Naccarato GA, Di Stefano R, Petronio AS, Di Bello V. Fabiani I, et al. Among authors: angelillis m. Sci Rep. 2018 Jul 2;8(1):9953. doi: 10.1038/s41598-018-28246-8. Sci Rep. 2018. PMID: 29967333 Free PMC article.
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.
Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, De Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S; GALILEO Investigators. Dangas GD, et al. N Engl J Med. 2020 Jan 9;382(2):120-129. doi: 10.1056/NEJMoa1911425. Epub 2019 Nov 16. N Engl J Med. 2020. PMID: 31733180 Free article. Clinical Trial.
Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis.
Testa L, Latib A, Brambilla N, De Marco F, Fiorina C, Adamo M, Giannini C, Angelillis M, Barbanti M, Sgroi C, Poli A, Ferrara E, Bruschi G, Russo CF, Matteo M, De Felice F, Musto C, Curello S, Colombo A, Tamburino C, Petronio AS, Bedogni F. Testa L, et al. Among authors: angelillis m. Eur Heart J. 2020 May 21;41(20):1876-1886. doi: 10.1093/eurheartj/ehz925. Eur Heart J. 2020. PMID: 31904800
39 results